Jazz Pharmaceuticals Announces Third Quarter 2021 Financial Results And Raises Full Year Earnings GuidancePRNewsWire • 11/09/21
Jazz Pharmaceuticals to Present Data Showcasing Clinical Advances Across Hematology/Oncology at ASH 2021 Annual MeetingPRNewsWire • 11/04/21
Jazz Pharmaceuticals to Report 2021 Third Quarter Financial Results on November 9, 2021PRNewsWire • 10/26/21
Jazz Pharmaceuticals: Narcolepsy Franchise Concerns Weigh On Investor SentimentSeeking Alpha • 10/19/21
Are These 2 Top Cannabis Stocks On Your List For September? 2 To Watch For Your Long Term PortfolioMarijuanaStocks • 09/14/21
Jazz Pharmaceuticals Announces Xywav® (calcium, magnesium, potassium, and sodium oxybates) Investor Webcast on October 13, 2021PRNewsWire • 09/13/21
Jazz (JAZZ) Down 14.1% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/02/21
Best Medical Marijuana Stocks To Buy In 2021? 2 Possible Long Term Investments Right NowMarijuanaStocks • 08/26/21
This Cannabis Stock Is Full of Potential and Hasn't Been This Cheap in MonthsThe Motley Fool • 08/17/21
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in AdultsPRNewsWire • 08/12/21